Travere Therapeutics Files 8-K on Operations and Financials
Ticker: TVTX · Form: 8-K · Filed: Feb 20, 2025 · CIK: 1438533
| Field | Detail |
|---|---|
| Company | Travere Therapeutics, Inc. (TVTX) |
| Form Type | 8-K |
| Filed Date | Feb 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: operations, financials, sec-filing
Related Tickers: TVTX
TL;DR
Travere Therapeutics (TVTX) filed an 8-K today covering financials and operations.
AI Summary
On February 20, 2025, Travere Therapeutics, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational updates were detailed in the provided excerpt.
Why It Matters
This 8-K filing indicates Travere Therapeutics is providing updates on its financial health and operational status to the SEC, which is important for investors to monitor.
Risk Assessment
Risk Level: low — The filing is a routine 8-K reporting operational and financial information, not indicating any immediate or significant negative events.
Key Players & Entities
- Travere Therapeutics, Inc. (company) — Registrant
- Retrophin, Inc. (company) — Former Company Name
- Desert Gateway, Inc. (company) — Former Company Name
- February 20, 2025 (date) — Date of Report
FAQ
What specific financial results are being reported by Travere Therapeutics?
The provided excerpt of the 8-K filing indicates that it concerns 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail specific financial figures.
When was this 8-K report filed?
The report was filed on February 20, 2025.
What is the principal executive office address for Travere Therapeutics?
The address is 3611 Valley Centre Drive, Suite 300, San Diego, CA 92130.
Has Travere Therapeutics changed its name previously?
Yes, the company was formerly known as Retrophin, Inc. (name change effective February 20, 2013) and Desert Gateway, Inc. (name change effective June 25, 2008).
What is the SIC code for Travere Therapeutics?
The Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 20, 2025 regarding Travere Therapeutics, Inc. (TVTX).